Dyadic International Inc (DYAI)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

140 INTRACOASTAL POINTE DRIVE JUPITER, FL 33477

Dyadic International, Inc. operates as a biotechnology company. The company uses its patented and proprietary technologies to conduct research and development activities for the discovery, development, and manufacture of products and enabling solutions to the bioenergy, industrial enzyme, and pharmaceutical industries. The company?s BioEnergy business develops strains, enzyme mixes, and related processes and manufacturing technologies for producing fermentable sugars from agricultural residues and energy crops, which would be used in the manufacture of cellulosic ethanol and other biomolecules derived from petroleum. Dyadic International's Enzyme business manufactures enzymes and other biological products for various industrial and commercial applications. The company sells approximately 55 liquid and dry enzyme products to approximately 200 industrial customers in approximately 50 countries for the textile, pulp and paper, animal feed, food, starch, alcohol, and fuel ethanol industries. Its BioPharma business develops hosts for therapeutic protein production for the biopharmaceutical industry. The company has operations in the United States, Hong Kong and mainland China, Poland, and the Netherlands. Dyadic International has strategic collaborations with Moscow State University, the Russian Academy of Sciences, TNO Quality of Life, Bio-Technical Resources, The Scripps Research Institute, Polfa Tarchomin, and Martek BioSciences.

Data as of 2020-05-24
Market Cap164.54 Million Shares Outstanding27.469 Million Avg 30-day Volume232.113 Thousand
P/E Ratio Dividend Yield EPS-0.31
Price/Sales200.664 Price cash flow ratio52.1 Price free cash flow ratio-25.8
Book Value1.25 Price to Tangible Book4.8 Alpha0.04
Short Interest Ratio % Short Interest to Float R-squared0.016574
BETA0.436389 52-week High/Low8.0 / 2.51 Stddev0.143951
View SEC Filings from DYAI instead.

View recent insider trading info

Funds Holding DYAI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DYAI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KAYE JACK

  • Director
16,191 2020-02-27 2

JONES MATTHEW S. MANAGING DIR OF BD & LICENSING

  • Officer
0 2020-01-02 1

TCHELET RONEN VP OF RESEARCH AND BUS. DVLPMT

  • Officer
0 2020-01-02 9

RAWSON PING WANG CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-02 2

BUCKLAND BARRY

  • Director
0 2020-01-02 2

BOSE ARINDAM

  • Director
0 2020-01-02 2

HERBST SETH

  • Director
0 2020-01-02 1

TARNOK MICHAEL P.

  • Director
0 2020-01-02 2

EMALFARB MARK A PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
0 2020-01-02 1

FRANCISCO TRUST UNDER AGREEMENT DATED FEBRUARY 28, 1996

  • 10% Owner
3,781,849 2019-02-12 0

KITT BARRY M

  • 10% Owner
4,363,589 2015-12-31 0

KITT BARRY M

PINNACLE FUND L P

  • 10% Owner
1,959,172 2008-12-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments